Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve unaudited financial result ....
Awaiting price reaction for this filing.
Citurgia Biochemicals has informed BSE that its Board of Directors will meet on Saturday, 14th February 2026 to consider and approve the unaudited standalone financial results for the quarter ended 31st December 2025 (Q3 FY26). The notice has been issued under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. The company also reminded that the trading window for its directors, officers, designated employees, and connected persons has been closed since 1st January 2026 and will reopen 48 hours after the results are declared. No financial figures or business details have been disclosed in this filing — it is a routine advance intimation of the upcoming board meeting.
No direct impact on shareholders or stock price from this filing, as it is a standard procedural announcement with no actual numbers. Investors should watch for the Q3 FY26 results on or after 14th February 2026 for any meaningful updates on the company's financial performance.